Dr. David Breen, MD

NPI: 1285662361
Total Payments
$9,462
2024 Payments
$813.77
Companies
23
Transactions
430
Medicare Patients
460
Medicare Billing
$116,899

Payment Breakdown by Category

Food & Beverage$9,462 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,462 430 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $2,588 111 $0 (2024)
GlaxoSmithKline, LLC. $2,354 112 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,411 53 $0 (2024)
ABBVIE INC. $667.03 41 $0 (2024)
Shire North American Group Inc $445.97 23 $0 (2019)
PFIZER INC. $423.68 23 $0 (2024)
Gilead Sciences, Inc. $380.31 4 $0 (2023)
Supernus Pharmaceuticals, Inc. $313.59 21 $0 (2024)
Galvanize Therapeutics, Inc $148.65 1 $0 (2023)
Corium, LLC $126.00 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $813.77 41 AstraZeneca Pharmaceuticals LP ($331.15)
2023 $2,261 96 AstraZeneca Pharmaceuticals LP ($545.75)
2022 $1,780 85 Novo Nordisk Inc ($436.31)
2021 $1,196 54 Novo Nordisk Inc ($545.32)
2020 $868.60 47 GlaxoSmithKline, LLC. ($496.48)
2019 $673.79 33 GlaxoSmithKline, LLC. ($378.10)
2018 $802.97 34 Novo Nordisk Inc ($377.69)
2017 $1,067 40 Novo Nordisk Inc ($476.31)

All Payment Transactions

430 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
08/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.24 General
Category: Diabetes
07/30/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $18.33 General
Category: Diabetes
07/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $25.76 General
Category: RESPIRATORY
07/16/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.04 General
Category: PAIN
07/11/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Respiratory
07/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.62 General
Category: Respiratory
06/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $5.50 General
Category: Diabetes
05/29/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.82 General
Category: Diabetes
05/21/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Respiratory
05/21/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.24 General
Category: Diabetes
05/15/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.74 General
Category: Respiratory
05/13/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $17.64 General
Category: PAIN
05/07/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.38 General
Category: PAIN
05/06/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $21.43 General
Category: CNS Stimulant for ADHD
04/26/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.81 General
Category: Diabetes
04/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.99 General
Category: Respiratory
04/15/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.56 General
Category: RESPIRATORY
04/11/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $18.80 General
Category: Respiratory
04/03/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $34.33 General
Category: NEUROSCIENCE
03/14/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $17.07 General
Category: Diabetes
03/12/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $24.10 General
Category: PAIN
03/07/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Respiratory
03/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.74 General
Category: NEUROSCIENCE
03/05/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.65 General
Category: Diabetes
02/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.39 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 57 192 $29,345 $16,136
2022 3 91 383 $64,952 $35,657
2021 4 118 365 $62,656 $32,343
2020 5 194 567 $79,290 $32,763
Total Patients
460
Total Services
1,507
Medicare Billing
$116,899
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 37 156 $25,230 $14,302 56.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 36 $4,115 $1,834 44.6%
99350 Established patient home visit, typically 1 hour Office 2022 11 128 $27,942 $16,849 60.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 41 145 $24,183 $12,263 50.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 110 $12,826 $6,546 51.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 45 159 $30,852 $14,906 48.3%
99350 Established patient home visit, typically 60 minutes Office 2021 13 85 $18,556 $11,078 59.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 38 97 $11,752 $5,930 50.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 22 24 $1,497 $428.96 28.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 63 270 $32,746 $12,165 37.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 60 146 $28,330 $10,643 37.6%
99350 Established patient home visit, typically 60 minutes Office 2020 14 48 $10,478 $6,382 60.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 32 60 $3,564 $2,710 76.0%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 25 43 $4,172 $862.54 20.7%

About Dr. David Breen, MD

Dr. David Breen, MD is a Pediatrics healthcare provider based in Dansville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285662361.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Breen, MD has received a total of $9,462 in payments from pharmaceutical and medical device companies, with $813.77 received in 2024. These payments were reported across 430 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($9,462).

As a Medicare-enrolled provider, Breen has provided services to 460 Medicare beneficiaries, totaling 1,507 services with total Medicare billing of $116,899. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Pediatrics
  • Location Dansville, NY
  • Active Since 06/29/2006
  • Last Updated 03/25/2009
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1285662361

Products in Payments

  • TRELEGY ELLIPTA (Drug) $1,674
  • Ozempic (Drug) $1,077
  • VRAYLAR (Drug) $667.03
  • BREZTRI (Drug) $454.01
  • Rybelsus (Drug) $389.58
  • Epclusa (Drug) $380.31
  • MYDAYIS (Drug) $364.15
  • FASENRA (Biological) $336.41
  • Victoza (Drug) $318.76
  • FARXIGA (Drug) $317.20
  • RYBELSUS (Drug) $309.14
  • QELBREE (Drug) $295.23
  • AIRSUPRA (Drug) $292.54
  • Tresiba (Drug) $238.47
  • NURTEC ODT (Drug) $236.79
  • Xultophy 100/3.6 (Drug) $234.84
  • ANORO (Drug) $188.46
  • VYVANSE (Drug) $165.61
  • BREO (Drug) $162.06
  • NUCALA (Biological) $161.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Dansville